1, Livzon Group: 2150,000 yuan.
Company location: Guangdong
Industry: pharmaceutical manufacturing
In the third quarter of 2022, the company achieved a total revenue of 3 1.86 billion, a year-on-year increase of1.66%; Gross profit is 210.05 billion, and gross profit rate is 66.08%.
Second place, Daan gene: 65.438+88.5 million yuan.
Company location: Guangdong
Industry: Medical Devices
The quarterly report of Daan Gene in the third quarter of 2022 shows that the company achieved a total operating income of 2.66 billion yuan, a year-on-year increase of 23.46%; The gross profit is 65.438+88.5 million yuan, and the gross profit rate is 70.89%.
No.3, Dean's diagnosis: 65.438+78 million yuan.
Location of the company: Zhejiang
Industry: medical services
Dean Diagnostics' quarterly report in the third quarter of 2022 shows that the company achieved a total operating income of 4.876 billion yuan, a year-on-year increase of 37.48%; Gross profit is 65.438+0.78 billion yuan, and gross profit rate is 36.5%.
No.4, Mingde Bio: 65.438+53.6 million yuan
Company location: Hubei
Industry: Medical Devices
The quarterly report of the company in the third quarter of 2022 shows that the total revenue in the third quarter of 2022 was 2210.70 billion, a year-on-year increase of10.78.10.4%; Gross profit is 65,438+0.536 million, and gross profit rate is 69.29%.
No.5, watson biological:1.21.70 million yuan.
Company location: Yunnan
Industry: biological products
In the third quarter of 2022, the company achieved a total revenue of 654.38+358 million, a year-on-year increase of 74.24%; Gross profit1.21.70 million, with a gross profit margin of 89.58%.
Sixth place, Cape Biology: 956 million yuan.
Company location: Guangdong
Industry: Medical Devices
In the third quarter of 2022, Cape Bio-Company achieved a total revenue of141600 million, a year-on-year increase of104.33%; The gross profit is 956 million, and the gross profit rate is 67.49%.
Seventh place, Sheng Xiang Biology: 802 million yuan.
Company location: Hunan
Industry: Medical Devices
The quarterly report of the company in the third quarter of 2022 shows that the total revenue in the third quarter of 2022 was10.378 billion, a year-on-year increase of10.654, 38+0.25%; The gross profit is 802 million, and the gross profit margin is 58.2 1%.
Eighth place, Runda Medical: 798 million yuan.
Location of the company: Shanghai
Industry: medical services
In the third quarter of 2022, Runda Medical achieved a total revenue of 2.873 billion, a year-on-year increase of19.88%; The gross profit is 798 million, and the gross profit rate is 27.76%.
No.9, Huada Gene: 767 million yuan
Company location: Guangdong
Industry: Medical Devices
In the third quarter of 2022, BGC achieved a total revenue of135.3 billion, a year-on-year increase of-10.17%; The gross profit is 767 million, and the gross profit rate is 56.73%.
10, Shi Shuo biological: 632 million yuan.
Company location: Jiangsu
Industry: Medical Devices
In the third quarter of 2022, the company achieved a total revenue of 65.438+0.28 billion, a year-on-year increase of-654.38+0.32%; Gross profit is 632 million, and gross profit margin is 6 1.52%.
All the information in Southern Fortune Network does not constitute investment advice, and the stock market is risky, so investment needs to be cautious.